Skip to main content
. 2022 Feb 19;77:100006. doi: 10.1016/j.clinsp.2022.100006

Fig. 3.

Fig 3

(A) Myelin Basic Protein (MBP, green) immunofluorescence counterstained with 4′, 6-Diamidino-2-Phenylindole (DAPI, blue) in longitudinal spinal cord sections of mice submitted to spinal cord injury (control group). (B) Microphotograph of the spinal cord of an animal in control group labeled with MBP. (C) Digital zoom of the area selected in A. (D) Microphotograph of the spinal cord of an animal with SCI treated with GM1. (E) Digital zoom of the area selected in C. (F) Microphotograph of the spinal cord of an animal with SCI treated with erythropoietin. (G) Digital zoom of the area selected in E. (H) Microphotograph of the spinal cord of an animal with SCI treated with a GM1 + erythropoietin combination.